3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Burkitt Lymphoma
12
Myelodysplastic Syndromes
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Blast Crisis
3
Sarcoma, Myeloid
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Down Syndrome
2
Recurrence
1
Plasmablastic Lymphoma
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hematologic Neoplasms
1
HIV Infections
1
Acute Myeloid Leukemia With KMT2A Rearrangement
1
Interventions
Nuclear Medicine Department, Hospital
6
Magnetic Resonance Spectroscopy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Biopsy
5
Temozolomide
4
Irinotecan
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
dinutuximab
2
Cyclophosphamide
2
trametinib
1
tazemetostat
1
talazoparib
1
saponin QA-21V1
1
palbociclib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
dabrafenib
1
Vincristine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Cytarabine
×
30 days
×
Clear all
No trials found.